ICOPM · Registering as Listener

International Conference on Oncology and Personalized Medicine

22nd Apr – 23rd Apr 2027 Xilingol League, Mongolia Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICOPM
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Oncology and Personalized Medicine conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities

This track will explore the latest developments in personalized oncology, focusing on tailored treatment strategies based on individual genetic profiles. Discussions will include case studies and innovative approaches to enhance patient outcomes.

This session will delve into the role of biomarkers in the early detection and management of cancer. Researchers will present findings on novel biomarkers that can predict treatment responses and disease progression.

This track will examine the evolving landscape of immunotherapy in oncology, highlighting recent breakthroughs and clinical applications. Participants will engage in discussions about the challenges and opportunities in harnessing the immune system to combat cancer.

This session will focus on the complex interactions within the tumor microenvironment and their implications for cancer progression and therapy. Presentations will cover cellular and molecular mechanisms that influence tumor behavior.

This track will address the implementation of precision medicine in oncology, discussing both the strategies employed and the challenges faced in clinical practice. Experts will share insights on integrating genomic data into treatment plans.

This session will highlight the importance of translational research in oncology, focusing on how laboratory discoveries can be effectively translated into clinical applications. Participants will discuss successful case studies and future directions.

This track will showcase cutting-edge treatment modalities in oncology, including novel chemotherapeutic agents and targeted therapies. Researchers will present their findings on efficacy and safety profiles of these innovative treatments.

This session will explore the role of genomic and epigenomic alterations in cancer development and progression. Presentations will focus on how these changes can inform therapeutic strategies and patient management.

This track will address the unique challenges faced in pediatric oncology, including the need for tailored treatment approaches for younger patients. Discussions will include recent advancements and ongoing research in this critical area.

This session will examine the disparities in cancer care and outcomes across different populations. Researchers will present data and strategies aimed at addressing these inequities to improve access and treatment for all patients.

This track will provide a platform for discussing emerging trends and future directions in cancer research. Experts will share their visions for the next decade in oncology, including potential breakthroughs and areas of focus.

COPYRIGHT © 2026 International Conference on Oncology and Personalized Medicine. ALL RIGHTS RESERVED